Advertisement

Pharmacy

A hedge fund has ousted the billionaire family that controls OxyContin maker Purdue Pharma for its alleged role in fueling the nationwide opioid epidemic, The Wall Street Journal reports.

Advertisement

The executive vice president of oncology therapeutics at Gilead Sciences will leave the company to pursue another opportunity, the company announced this week.

Advertisement